Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Fortress Biotech (FBIO) Net Income towards Common Stockholders (2016 - 2025)

Fortress Biotech (FBIO) has 13 years of Net Income towards Common Stockholders data on record, last reported at $3.7 million in Q3 2025.

  • For Q3 2025, Net Income towards Common Stockholders rose 124.43% year-over-year to $3.7 million; the TTM value through Sep 2025 reached -$5.3 million, up 90.72%, while the annual FY2024 figure was -$55.9 million, 18.61% up from the prior year.
  • Net Income towards Common Stockholders reached $3.7 million in Q3 2025 per FBIO's latest filing, down from $13.4 million in the prior quarter.
  • Across five years, Net Income towards Common Stockholders topped out at $13.4 million in Q2 2025 and bottomed at -$62.3 million in Q4 2021.
  • Average Net Income towards Common Stockholders over 5 years is -$24.0 million, with a median of -$23.4 million recorded in 2022.
  • Peak YoY movement for Net Income towards Common Stockholders: tumbled 159.57% in 2021, then skyrocketed 200.12% in 2025.
  • A 5-year view of Net Income towards Common Stockholders shows it stood at -$62.3 million in 2021, then skyrocketed by 53.63% to -$28.9 million in 2022, then soared by 60.94% to -$11.3 million in 2023, then rose by 14.49% to -$9.7 million in 2024, then surged by 138.08% to $3.7 million in 2025.
  • Per Business Quant database, its latest 3 readings for Net Income towards Common Stockholders were $3.7 million in Q3 2025, $13.4 million in Q2 2025, and -$12.7 million in Q1 2025.